Dietitian home visits may boost quality of life in head and neck cancer patients
NCT ID NCT02510859
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether having a dietitian visit patients at home during radiotherapy could improve their quality of life. 117 adults with head and neck cancer took part. The goal was to see if personalized nutrition advice helps patients cope better with treatment side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- home dietary consultation
- What this could lead to
- If it works, this could show that simple nutritional support at home improves quality of life for head and neck cancer patients during radiotherapy.
- What could go wrong
- This is a completed trial, but the primary outcome is a subjective quality-of-life score, which may not show a clear benefit. The intervention is supportive care, not a treatment for the cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
117 people
The number who actually took part.
- Start date
-
Dec 2010
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients over 18 years * having Given written consent * Life span \> 3 months * Score WHO \<3 * Patient With cancer of Aero-Digestive tract Superior histologically proven (including salivary glands) * Stable , presenting no other progressive neoplasia except VADS * Patient to be treated with radiotherapy alone or concomitant chemoradiotherapy or radiotherapy with cetuximab or postoperative radiotherapy roughly sensitized. * Patient Fluent French. Exclusion Criteria: * Patient with history of malignancy, except basal cell cancer or neck cancer treated and cured * Patient who underwent salvage surgery other than a course node, * Patient with other evolutionary neoplasia at the time of examination * Patient having previously had a mutilating surgery (causing effects on swallowing and feeding) * Uncontrolled infectious disease * Lactating or pregnant women or lack of contraception in reproductive years * Intercurrent pathology involving life-threatening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Squamous cell carcinoma of the head and neck are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service ORL et de chirurgie cervico- faciale
Caen CHU, 14000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lighting up oral cancer: dye may help surgeons see tumor edges
- Blood test aims to catch Cancer's return earlier
- Can a new targeted drug outperform standard therapy for advanced head and neck cancer?
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new drug boost the power of chemoradiation against head and neck cancer?
- Experimental antibody combo aims to boost immune attack on head and neck tumors